List of Tables
Table 1. Lung Cancer Therapy Market Trends
Table 2. Lung Cancer Therapy Market Drivers & Opportunity
Table 3. Lung Cancer Therapy Market Challenges
Table 4. Lung Cancer Therapy Market Restraints
Table 5. Global Lung Cancer Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Lung Cancer Therapy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Lung Cancer Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Lung Cancer Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Lung Cancer Therapy
Table 10. Global Lung Cancer Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Lung Cancer Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Lung Cancer Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Lung Cancer Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Lung Cancer Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Lung Cancer Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Lung Cancer Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Lung Cancer Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Lung Cancer Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Lung Cancer Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Lung Cancer Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Lung Cancer Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Lung Cancer Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Lung Cancer Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Lung Cancer Therapy Sales Value by Region (2019-2024) & (%)
Table 27. Global Lung Cancer Therapy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Lung Cancer Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Lung Cancer Therapy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Lung Cancer Therapy Sales Value, (2025-2030) & (US$ Million)
Table 31. GlaxoSmithKline Basic Information List
Table 32. GlaxoSmithKline Description and Business Overview
Table 33. GlaxoSmithKline Lung Cancer Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Lung Cancer Therapy Business of GlaxoSmithKline (2019-2024)
Table 35. GlaxoSmithKline Recent Developments
Table 36. Menarini Basic Information List
Table 37. Menarini Description and Business Overview
Table 38. Menarini Lung Cancer Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Lung Cancer Therapy Business of Menarini (2019-2024)
Table 40. Menarini Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Lung Cancer Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Lung Cancer Therapy Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. Roche Basic Information List
Table 47. Roche Description and Business Overview
Table 48. Roche Lung Cancer Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Lung Cancer Therapy Business of Roche (2019-2024)
Table 50. Roche Recent Developments
Table 51. Merck Basic Information List
Table 52. Merck Description and Business Overview
Table 53. Merck Lung Cancer Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Lung Cancer Therapy Business of Merck (2019-2024)
Table 55. Merck Recent Developments
Table 56. AstraZeneca Basic Information List
Table 57. AstraZeneca Description and Business Overview
Table 58. AstraZeneca Lung Cancer Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Lung Cancer Therapy Business of AstraZeneca (2019-2024)
Table 60. AstraZeneca Recent Developments
Table 61. Sanofi-Aventis Basic Information List
Table 62. Sanofi-Aventis Description and Business Overview
Table 63. Sanofi-Aventis Lung Cancer Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Lung Cancer Therapy Business of Sanofi-Aventis (2019-2024)
Table 65. Sanofi-Aventis Recent Developments
Table 66. Eli Lilly and Company Basic Information List
Table 67. Eli Lilly and Company Description and Business Overview
Table 68. Eli Lilly and Company Lung Cancer Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Lung Cancer Therapy Business of Eli Lilly and Company (2019-2024)
Table 70. Eli Lilly and Company Recent Developments
Table 71. Abbott Basic Information List
Table 72. Abbott Description and Business Overview
Table 73. Abbott Lung Cancer Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Lung Cancer Therapy Business of Abbott (2019-2024)
Table 75. Abbott Recent Developments
Table 76. Akebia Therapeutics Basic Information List
Table 77. Akebia Therapeutics Description and Business Overview
Table 78. Akebia Therapeutics Lung Cancer Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Lung Cancer Therapy Business of Akebia Therapeutics (2019-2024)
Table 80. Akebia Therapeutics Recent Developments
Table 81. Agennix AG Basic Information List
Table 82. Agennix AG Description and Business Overview
Table 83. Agennix AG Lung Cancer Therapy Products, Services and Solutions
Table 84. Revenue (US$ Million) in Lung Cancer Therapy Business of Agennix AG (2019-2024)
Table 85. Agennix AG Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Lung Cancer Therapy Downstream Customers
Table 89. Lung Cancer Therapy Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Lung Cancer Therapy Product Picture
Figure 2. Global Lung Cancer Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Lung Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Lung Cancer Therapy Report Years Considered
Figure 5. Global Lung Cancer Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Lung Cancer Therapy Revenue in 2023
Figure 7. Lung Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Radiation Therapy Picture
Figure 9. Chemotherapy Picture
Figure 10. Targeted Therapies Picture
Figure 11. Immunotherapy Picture
Figure 12. Global Lung Cancer Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Lung Cancer Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospitals
Figure 15. Product Picture of Clinics
Figure 16. Product Picture of Other
Figure 17. Global Lung Cancer Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Lung Cancer Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Lung Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Lung Cancer Therapy Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Lung Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Lung Cancer Therapy Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Lung Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Lung Cancer Therapy Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Lung Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Lung Cancer Therapy Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Lung Cancer Therapy Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Lung Cancer Therapy Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Lung Cancer Therapy Sales Value (%), (2019-2030)
Figure 30. United States Lung Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Lung Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Lung Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Lung Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Lung Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Lung Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 36. China Lung Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Lung Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 38. China Lung Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Lung Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Lung Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Lung Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Lung Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Lung Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Lung Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Lung Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Lung Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Lung Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 48. India Lung Cancer Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Lung Cancer Therapy Sales Value by Type (%), 2023 VS 2030
Figure 50. India Lung Cancer Therapy Sales Value by Application (%), 2023 VS 2030
Figure 51. Lung Cancer Therapy Industrial Chain
Figure 52. Lung Cancer Therapy Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
